My project is part of the European TRAIN-ASAP programme (Training and Research AImed at Novel Antibacterial Solutions in Animal and People). It is a Marie Curie Initial Training Network funded by the 7th framework of the European Commission. The project is dedicated to the training of 14 early-stage researchers (ESRs) based in 10 different European countries and whose research is aimed at the development of novel antibacterial solutions for humans and animals.
9 academic institutions, including the University of Warwick, 8 private enterprises, including Pfizer, and 2 national research centres are involved in this programme.
The lines of research are diverse: from the study of poorly explored potential sources of new antibiotics to the development of alternative treatments like phage therapy. At the end of the three-year research period, a prize will be awarded for the most promising/successful project.
All partners and researchers involved in TRAIN-ASAP regularly met for a series of seminars and discussions about bacterial resistance, and also to follow progress made by the ESRs. The programme came to an end at the ICOHAR conference in Copenhagen, Denmark, in September 2015.